Literature DB >> 31844396

Iron requirements in the first 2 years of life.

Sharon L Unger1, Tanis R Fenton1, Radha Jetty1, Jeff N Critch1, Deborah L O'connor1.   

Abstract

Iron is an essential micronutrient required for hemoglobin synthesis, central nervous system development, and protection from infection. Early childhood is a time of vulnerability as iron deficiency in this period is associated with impaired neurodevelopment. Low socioeconomic status, preterm birth, and suboptimal diet are risk factors for iron deficiency. Due to a lack of iron excretory mechanism, the possibility of iron excess also exists. Appropriate iron intake in the first 2 years of life is critical. © Canadian Paediatric Society 2019. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Anemia; Complementary feeding; Infant nutrition; Iron deficiency; Iron requirements

Year:  2019        PMID: 31844396      PMCID: PMC6901162          DOI: 10.1093/pch/pxz148

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  3 in total

Review 1.  Follow-up care of the extremely preterm infant after discharge from the neonatal intensive care unit.

Authors:  Leonora Hendson; Paige T Church; Rudaina Banihani
Journal:  Paediatr Child Health       Date:  2022-10-03       Impact factor: 2.600

Review 2.  Le suivi de l'extrême prématuré après le congé des soins intensifs néonatals.

Authors:  Leonora Hendson; Paige T Church; Rudaina Banihani
Journal:  Paediatr Child Health       Date:  2022-10-03       Impact factor: 2.600

3.  Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency.

Authors:  Timothy M Bahr; Nicholas R Carr; Thomas R Christensen; Jacob Wilkes; Elizabeth A O'Brien; Kendell R German; Robin K Ohls; Diane M Ward; Robert D Christensen
Journal:  Blood Cells Mol Dis       Date:  2021-05-06       Impact factor: 2.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.